The pursuit of more effective and targeted cancer therapies is spurring the evolution of antibody-based treatments. At the Antibody-based Cancer Therapies conference, we will explore the potential of emerging antibody formats that are driving the oncology field, including mAbs, cytokines, bispecifics, antibody-based cell therapies, conditionally active biologics, etc., as well as examine novel targets and approaches to overcome efficacy and toxicity challenges in developing these exciting new modalities.